Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.50 |
| ▸ | OPRK1 | P41145 | 6/20 | 0.49 |
| ▸ | USP2 | O75604 | 2/20 | 0.49 |
| ▸ | THRB | P10828 | 2/20 | 0.49 |
| ▸ | RGS12 | O14924 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | PKM | P14618 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.49 |
| ▸ | CASP1 | P29466 | 1/20 | 0.49 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.49 |
| ▸ | THPO | P40225 | 1/20 | 0.49 |
| ▸ | CASP7 | P55210 | 1/20 | 0.49 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.49 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL38374 | 1.00 | SLC7A5 (0.50) | SLC7A5OPRK1USP2THRBRGS12 | |
| SCHEMBL10608422 | 1.00 | SLC7A5 (0.50) | SLC7A5OPRK1USP2THRBRGS12 | |
| Hydrochloric Acid SCHEMBL10421601 | 0.98 | SLC7A5 (0.49) | SLC7A5OPRK1USP2THRBRGS12 | |
| Hydrochloric Acid SCHEMBL10477430 | 0.98 | SLC7A5 (0.49) | SLC7A5OPRK1USP2THRBRGS12 | |
| Bromide SCHEMBL10477399 | 0.98 | SLC7A5 (0.49) | SLC7A5OPRK1USP2THRBRGS12 | |
| Bromide SCHEMBL10477401 | 0.98 | SLC7A5 (0.49) | SLC7A5OPRK1USP2THRBRGS12 | |
| SCHEMBL4880533 | 0.91 | USP2 (0.49) | SLC7A5OPRK1USP2THRBRGS12 | |
| SCHEMBL45405 | 0.91 | USP2 (0.49) | SLC7A5OPRK1USP2THRBRGS12 | |
| Tyrosine SCHEMBL28486531 | 0.89 | SLC7A5 (0.71) | SLC7A5OPRK1USP2THRBCYP3A4 | |
| SCHEMBL29141120 | 0.89 | USP2 (0.46) | SLC7A5OPRK1USP2THRBRGS12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 565 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12600699-B2 | Thiosemicarbazates and uses thereof | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) | 2026-04-14 | — | — | US | claimed |
| US-20250325672-A1 | ANTI-INFECTIVE BICYCLIC PEPTIDE LIGANDS | BICYCLE TX LTD (GB) | 2025-10-23 | — | — | US | claimed |
| US-12390424-B2 | Sulfur (VI) fluoride compounds and methods for the preparation thereof | THE SCRIPPS RESEARCH INSTITUTE (US) | 2025-08-19 | — | — | US | claimed |
| US-12351573-B2 | Compounds for use in synthesis of peptidomimetics | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) | 2025-07-08 | — | — | US | claimed |
| WO-2025044786-A1 | PEPTIDES, DERIVATIVES THEREOF, AND USE OF SAME | 南京医科大学 | 2025-03-06 | — | — | WO | claimed |
| US-20240382605-A1 | CONJUGATED OLIGONUCLEOTIDES AND USES THEREOF | IONIS PHARMACEUTICALS, INC. (US) | 2024-11-21 | — | — | US | claimed |
| EP-4274838-B1 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NK CELLS | BICYCLETX LTD (GB) | 2024-09-25 | — | — | EP | claimed |
| EP-4408433-A1 | CONJUGATED OLIGONUCLEOTIDES AND USES THEREOF | Ionis Pharmaceuticals, Inc. (US) | 2024-08-07 | — | — | EP | claimed |
| CN-111689929-B | Sulfur fluoride (VI) compound and preparation method thereof | 斯克里普斯研究所 | 2024-05-31 | — | — | CN | claimed |
| US-20240108738-A1 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NK CELLS | BICYCLETX LIMITED (GB) | 2024-04-04 | — | — | US | claimed |
| CN-1938042-A | Methods for mitigating oxidative damage | CORNELL RES FOUNDATION INC (US) | 2007-03-28 | — | — | CN | claimed |
| WO-2006064133-A2 | NOVEL MULTIMERIC CD40 LIGANDS, METHOD FOR PREPARING SAME AND USE THEREOF FOR PREPARING DRUGS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2006-06-22 | — | — | WO | claimed |
| CN-1787831-A | Method for preventing mitochondrial permeability transition | CORNELL RES FOUNDATION INC (US) | 2006-06-14 | — | — | CN | claimed |
| EP-0644772-B1 | OPIOID PEPTIDES | SOD CONSEILS RECH APPLIC (FR) | 2003-04-02 | — | — | EP | claimed |
| CN-1200127-A | Novel opioid peptides | ASTRA AB (SE) | 1998-11-25 | — | — | CN | claimed |
| US-5663295-A | ANALGESIC, ANTIDIARRHEA | BIOMEASURE INC. (US) | 1997-09-02 | — | — | US | claimed |
| EP-0644772-A4 | OPIOID PEPTIDES. | BIOMEASURE INC (US) | 1997-01-29 | — | — | EP | claimed |
| EP-0644772-A1 | OPIOID PEPTIDES | BIOMEASURE, INC. (US) | 1995-03-29 | — | — | EP | claimed |
| WO-1994011018-A1 | OPIOID PEPTIDES | BIOMEASURE, INC. (US) | 1994-05-26 | — | — | WO | claimed |
| US-4273704-A | N-Adamantane-substituted tetrapeptide amides | G. D. SEARLE & CO. (US) | 1981-06-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12351573-B2 | Compounds for use in synthesis of peptidomimetics | DNPEP, NPEPPS, PAM | SLC7A5 1166/4885OPRK1 2628/4885USP2 2161/4885 |
| US-20250325672-A1 | ANTI-INFECTIVE BICYCLIC PEPTIDE LIGANDS | ACE2, SARS1, TMPRSS2 | SLC7A5 2440/4885OPRK1 2039/4885USP2 2557/4885 |
| US-12390424-B2 | Sulfur (VI) fluoride compounds and methods for the preparation thereof | GRB2, SCTR, OGFR | SLC7A5 459/4885OPRK1 942/4885USP2 2537/4885 |
| US-20240108738-A1 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NK CELLS | PBK, KLRK1, MICA | SLC7A5 1881/4885OPRK1 1486/4885USP2 4659/4885 |
| US-20240382605-A1 | CONJUGATED OLIGONUCLEOTIDES AND USES THEREOF | DCLRE1B, PLK1, PAICS | SLC7A5 540/4885OPRK1 3025/4885USP2 4789/4885 |
| US-12600699-B2 | Thiosemicarbazates and uses thereof | MET, THRB, ABAT | SLC7A5 64/4885OPRK1 2051/4885USP2 1460/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.